Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of Kaposi's sarcoma with IL-12

Treatment of Kaposi's sarcoma with IL-12

US Patent 6423308 · Granted Jul 23, 2002

Estimated economic value: $229,341,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Receptor tyrosine kinase inhibitors for treatment of protein kinase modulation-r2025
Methods for treating vascular eye disorders with ActRII antagonists2022
Methods of preparing a re-usable single cell and methods for analyzing the epige2022
Methods for treating vascular eye disorders with actrii antagonists2020
Antagonists of activin-ActRIIa and uses for increasing red blood cell levels2018
Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using imm2018
Follistatin fusion proteins and uses thereof2018
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and he2016
Activin-actriia antagonists for treating a follicle-stimulating horomone-secreti2016
Antagonists of activin-actriia and uses for increasing red blood cell levels2014
Induced internalization of surface receptors2013
Activin-actriia antagonists for inhibiting germ cell maturation2013